Curanex Pharmaceuticals (NASDAQ:CURX) Releases Quarterly Earnings Results

Curanex Pharmaceuticals (NASDAQ:CURX) issued its earnings results on Thursday. The company reported ($0.11) earnings per share for the quarter, FiscalAI reports.

Curanex Pharmaceuticals Price Performance

Shares of CURX traded down $0.00 during mid-day trading on Friday, reaching $0.31. The company’s stock had a trading volume of 47,789 shares, compared to its average volume of 2,940,786. Curanex Pharmaceuticals has a 12-month low of $0.26 and a 12-month high of $9.18. The stock has a market cap of $8.73 million and a PE ratio of -1.81. The company’s 50 day moving average is $0.43 and its 200 day moving average is $0.42.

Analysts Set New Price Targets

Separately, Weiss Ratings raised Curanex Pharmaceuticals from a “sell (e)” rating to a “sell (e+)” rating in a research note on Friday, May 1st. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

Hedge Funds Weigh In On Curanex Pharmaceuticals

A hedge fund recently bought a new stake in Curanex Pharmaceuticals stock. Citadel Advisors LLC bought a new stake in Curanex Pharmaceuticals Inc (NASDAQ:CURX) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 64,067 shares of the company’s stock, valued at approximately $46,000.

About Curanex Pharmaceuticals

Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances. We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections.